Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
OpGen revenue
OpGen's revenue is $3.4 million.
What is OpGen's revenue?
- OpGen's revenue growth from 2014 to 2023 is -17.16%.
- OpGen has 48 employees, and the revenue per employee ratio is $71,215.
- OpGen's peak quarterly revenue was $1.4M in 2021(q4).
- OpGen peak revenue was $4.3M in 2021.
- OpGen annual revenue for 2022 was 2.6M, -39.45% growth from 2021.
- OpGen annual revenue for 2023 was 3.4M, 31.11% growth from 2022.
On this page
Zippi applies for you, and finds you a job.
OpGen historical revenue
OpGen's peak revenue was $4.3M in 2021. The peak quarterly revenue was $1.4M in 2021(q4).
OpGen's revenue increased from $4.1m in 2014 to $3.4M currently. That's a -17.16% change in annual revenue.
OpGen annual revenue
OpGen annual revenue over time
| Fiscal year / year | OpGen revenue |
|---|---|
| 2014 | $4.1M |
| 2015 | $3.2M |
| 2016 | $4.0M |
| 2017 | $3.2M |
| 2018 | $2.9M |
| 2019 | $3.5M |
| 2020 | $4.2M |
| 2021 | $4.3M |
| 2022 | $2.6M |
| 2023 | $3.4M |
Rate OpGen's financial transparency
OpGen annual growth
OpGen saw the greatest revenue growth in 2016, when revenue increased by 27.49%.
OpGen had the lowest revenue growth in 2022, when revenue changed by -39.45%.
OpGen annual growth rate over time
| Year | OpGen growth |
|---|---|
| 2015 | -23%↓ |
| 2016 | 27%↑ |
| 2017 | -20%↓ |
| 2018 | -8%↓ |
| 2019 | 19%↑ |
| 2020 | 20%↑ |
| 2021 | 2%↑ |
| 2022 | -39%↓ |
| 2023 | 31%↑ |
OpGen quarterly revenue over time
- Q1
- Q2
- Q3
- Q4
OpGen quarterly growth rate over time
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2014 | - | - | - | $1.1M |
| 2015 | $472,200 | $375,146 | $980,786 | $1.3M |
| 2016 | $1.1M | $1.2M | $759,663 | $1.0M |
| 2017 | $771,771 | $703,210 | $745,114 | $990,912 |
| 2018 | $846,226 | $788,901 | $552,221 | $758,959 |
| 2019 | $1.0M | $1.0M | $648,220 | $820,674 |
| 2020 | $616,933 | $1.2M | $1.1M | $1.4M |
| 2021 | $829,716 | $811,615 | $1.2M | $1.4M |
| 2022 | $469,745 | $967,205 | $448,713 | $721,630 |
| 2023 | $913,444 | $736,137 | $699,022 | $1.1M |
| 2024 | $168,149 | $28,000 | - | - |
OpGen jobs nearby
Do you work at OpGen?
Did OpGen meet its revenue projections?
OpGen financial information
| CEO | Evan Jones |
| Industry | Software & Services |
| Company Type | Public |
| Employees Number | 48 |
| Date Founded | 2002 |
| Headquarters | Gaithersburg, Maryland |
| Number of Locations | 2 |
| Revenue | $3.4M |
| Net Income | -$37,283,233 |
| Gross Proft | -$90,694 (2023) |
| PE Ratio | -0.50 |
| Tax Rate | -0.0% |
| Market Capitalization | $16.5M |
| Total Assets | $25,813,149 |
| Ticker | OPGN |
OpGen jobs you might like
OpGen financing
OpGen received early financing of $5.0M on 2005-01-27.
| Series | Round size | Date |
|---|---|---|
| Series B | $5M | 01/2005 |
| Series Unknown | $23.6M | 09/2007 |
| Debt Financing | $4M | 01/2010 |
| Debt Financing | $4M | 05/2010 |
| Series B | $17M | 09/2010 |
| Debt Financing | $3.5M | 02/2012 |
| Series C | $17M | 03/2012 |
| Debt Financing | $4.0M | 04/2014 |
| Debt Financing | $1M | 07/2014 |
| Debt Financing | $1.2M | 02/2015 |
| Post Ipo Equity | $6M | 07/2015 |
| Post Ipo Equity | $10.4M | 05/2016 |
| Post Ipo Equity | $10M | 07/2017 |
| Post Ipo Equity | $12M | 02/2018 |
| Post Ipo Equity | $5.4M | 03/2019 |
| Post Ipo Equity | $9.4M | 10/2019 |
| Post Ipo Equity | $10M | 11/2020 |
| Post Ipo Equity | $15M | 10/2021 |
OpGen investors
| Investors | Security type |
|---|---|
| State of Wisconsin Investment Board | Series B |
| Stonehenge Capital | Series B |
| MASON WELLS | Series B |
| Wisconsin Alumni Research Foundation | Series B |
| Highland Capital Partners | Series Unknown |
| CHL Medical Partners | Series Unknown |
| Versant Ventures | Series Unknown |
| MASON WELLS | Series Unknown |
| In Q Tel | Series Unknown |
| Highland Capital Partners | Series B |
| CHL Medical Partners | Series B |
| Versant Ventures | Series B |
| MASON WELLS | Series B |
| jVen Capital LLC | Series B |
| Highland Capital Partners | Series C |
| CHL Medical Partners | Series C |
| Versant Ventures | Series C |
| 180 Degree Capital Corp. | Series C |
| jVen Capital LLC | Series C |
| Cross Creek | Series C |
| Merck & Co. Inc. | Post Ipo Equity |
| SABBY MANAGEMENT LLC | Post Ipo Equity |
| Merck & Co. Inc. | Post Ipo Equity |
OpGen competitors
OpGen's top competitor, OPKO Health, earned an annual revenue of $713.1M.
OpGen's smallest competitor is Genetics Institute with revenue of $7.5M last year.
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| OPKO Health | $71,885 | $713.1M | 6,096 | 3 |
| Lucigen | $50,032 | $15.7M | 20 | - |
| GENEWIZ | $53,660 | $45.4M | 100 | - |
| ABC Laboratories | $72,507 | $72.0M | 3,000 | 3 |
| Protein Sciences | $66,430 | $23.9M | 150 | - |
| Genetics Institute | $66,378 | $7.5M | 500 | - |
| Nanogen | $54,140 | $8.5M | 10 | - |
Search for jobs
Related company revenues
Working at related companies
Related company jobs
Most in demand jobs
Zippia gives an in-depth look into the details of OpGen, including salaries, political affiliations, employee data, and more, in order to inform job seekers about OpGen. The employee data is based on information from people who have self-reported their past or current employments at OpGen. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by OpGen. The data presented on this page does not represent the view of OpGen and its employees or that of Zippia.
OpGen may also be known as or be related to OPGEN INC, OpGen, OpGen Inc, OpGen Inc., OpGen, Inc., Opgen and Opgen, Inc.